A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients
Clinical trial NCT02854072 · UNKNOWN
Trial details
- NCT number
- NCT02854072
- Sponsor
- Samsung Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2018-05-01
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.